A team of scientists led by researchers at the University of Cambridge has made a fundamental discovery about how the properties of embryonic stem cells are controlled. The findings, published in the journal Nature, could have important implications for regenerative medicine and our understanding of early human development.

Embryonic stem cells are pluripotent, meaning they have the potential to develop into any cell type in the body. This makes them a promising source of cells for regenerative medicine, but it also means that they are difficult to control. Scientists need to be able to direct embryonic stem cells to differentiate into specific cell types without causing them to lose their pluripotency.

The new study has identified a key molecular mechanism that controls the pluripotency of embryonic stem cells. The researchers found that a protein called Oct4 is essential for maintaining the stem cells' pluripotency. When Oct4 is depleted, the stem cells lose their ability to differentiate into other cell types.

This discovery could lead to new ways to control the differentiation of embryonic stem cells for regenerative medicine. By manipulating the levels of Oct4, scientists may be able to direct stem cells to differentiate into specific cell types without causing them to lose their pluripotency. This would make it possible to grow new cells and tissues for transplantation, which could revolutionize the treatment of a wide range of diseases.

The study also has implications for our understanding of early human development. Oct4 is expressed in the early embryo, and it is thought to play a role in regulating the differentiation of embryonic stem cells. The new findings provide further evidence for Oct4's role in early human development, and they could help us to better understand how embryos develop.

The study was led by Dr. Austin Smith, Professor of Stem Cell Biology and Medicine at the University of Cambridge. Dr. Smith said: "This is a fundamental discovery that could have important implications for regenerative medicine and our understanding of early human development. We now know that Oct4 is essential for maintaining the pluripotency of embryonic stem cells, and we can use this knowledge to control the differentiation of stem cells for regenerative medicine."

The study was funded by the Wellcome Trust, the Medical Research Council, and the Biotechnology and Biological Sciences Research Council.